News
TEVA ▼ -0.8% - Teva Pharmaceutical Industries Limited
TEVA ▼ -0.8% - Teva Pharmaceutical Industries Limited
$TEVA - Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)
28-SEP-2026 04:00 PM ET
Share this post
More filings for $TEVA
TEVA ▲ +0.5% - Teva Pharmaceutical Industries LimitedOct 12, 2026TEVA ▲ +4.0% - Teva Pharmaceutical Industries LimitedOct 9, 2026TEVA ▲ +3.2% - Teva Pharmaceutical Industries LimitedOct 9, 2026TEVA ▼ -0.4% - Teva Pharmaceutical Industries LimitedOct 2, 2026TEVA ▼ -1.2% - Teva Pharmaceutical Industries LimitedSep 23, 2026TEVA ▼ -1.2% - Teva Pharmaceutical Industries LimitedSep 23, 2026
View full $TEVA filing history →💬 Comments
Loading comments…
Leave a comment